Table 1.
Variable | NAFLD −CVD | NAFLD +CVD | P value |
---|---|---|---|
Mean age±s.d. (years) | 52.3±14.1 | 61.9±13.1 | <0.0001 |
Gender; no. (%) | |||
Male | 2,652 (51.3%) | 1,789 (55.2%) | 0.0006 |
Female | 2,514 (48.7%) | 1,454 (44.8%) | — |
Ethnicity; no. (%) | |||
White | 3,399 (87.1%) | 2,574 (92.6%) | <0.0001 |
African American | 296 (7.6%) | 146 (5.25%) | — |
Other | 206 (5.3%) | 60 (2.2%) | — |
BMI±s.d (kg/m2) | 33.4±7.6 | 33.3±10.6 | 0.30 |
Obesity; no. (%) | 1,747 (33.8%) | 1,074 (33.1%) | 0.51 |
Diabetes mellitus; no. (%) | 3,340 (64.7%) | 2,651 (82.0%) | <0.0001 |
Hypertension; no. (%) | 2,946 (57.0%) | 2,745 (84.6%) | <0.0001 |
Family history of CVD; no. (%) | 3,014 (58.3%) | 2,172 (67.0%) | <0.0001 |
Renal failure; no. (%) | 363 (7.0%) | 546 (16.8%) | <0.0001 |
LDL±s.d. (mg/dl) | 112.5±38.2 | 106.3±38.8 | <0.0001 |
Non-HDL-C±s.d. (mg/dl) | 189.7±63.6 | 182.3±58.8 | <0.0001 |
Albumin±s.d. (g/dl) | 3.9±0.69 | 3.7±0.63 | <0.0001 |
Sodium±s.d. (mmol/l) | 139.0±2.9 | 138.0±2.7 | <0.0001 |
MELD score±s.d. | 10.2±5.0 | 12.3±5.7 | <0.0001 |
BMI, body mass index; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; MELD, Model for End-Stage Liver Disease; NAFLD, nonalcoholic fatty liver disease.